FdaApplication
NDA 020044
Identifiers
- fda_app_no: NDA020044
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1990-08-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EXOSURF NEONATAL | CETYL ALCOHOL; COLFOSCERIL PALMITATE; TYLOXAPOL | 12MG/VIAL;108MG/VIAL;8MG/VIAL | FOR SUSPENSION;INTRATRACHEAL |
1 product